BioCryst Pharmaceuticals Inc. (BCRX)
NASDAQ · Healthcare
BioCryst Pharmaceuticals Inc. Gross Profit 2009–2025
BioCryst Pharmaceuticals Inc. annual/quarterly gross profit history and growth rate from 2009 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- BioCryst Pharmaceuticals Inc. gross profit for the quarter ending March 31, 2026 was 151.0 M, a 7.14% increase year-over-year.
- BioCryst Pharmaceuticals Inc. gross profit for the twelve months ending March 31, 2026 was 609.8 M, a 52.96% increase year-over-year.
- BioCryst Pharmaceuticals Inc. annual gross profit for 2025 was 855.8 M, a 95.18% increase from 2024.
- BioCryst Pharmaceuticals Inc. annual gross profit for 2024 was 438.4 M, a 34.11% increase from 2023.
- BioCryst Pharmaceuticals Inc. annual gross profit for 2023 was 326.9 M, a 23.64% increase from 2022.
- BioCryst Pharmaceuticals Inc. annual gross profit for 2022 was 264.4 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BioCryst Pharmaceuticals Inc. Gross Profit — FAQ
BioCryst Pharmaceuticals Inc. (BCRX) gross profit over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is BioCryst Pharmaceuticals Inc.'s gross profit?
BioCryst Pharmaceuticals Inc. (BCRX) reported gross profit of $856M for fiscal 2025.
Where can I see BCRX's gross profit history?
The chart and table above show BioCryst Pharmaceuticals Inc.'s gross profit by year and by quarter, including the growth rate.